The epidemiology, etiology, and pathophysiology of onychomycosis

Seminars in Cutaneous Medicine and Surgery

Volumn 32, Issue , 2013, Pages S2-S4

  Scher, Richard K ^a   Rich, Phoebe ^b   Pariser, David ^c   Elewski, Boni ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Fungal infections; Nail infections; Onychomycosis; Trichophyton rubrum

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

ACREMONIUM; AGING; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FAMILY HISTORY; FINGERNAIL ONYCHOMYCOSIS; FUSARIUM; HUMAN; IMMUNOCOMPROMISED PATIENT; NAIL PSORIASIS; NONHUMAN; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON RUBRUM; AGE; HEALTH; ISOLATION AND PURIFICATION; MICROBIOLOGY; NAIL; ONYCHOMYCOSIS; REVIEW; TRICHOPHYTON;

AGE FACTORS; HUMANS; NAILS; ONYCHOMYCOSIS; PREVALENCE; TRICHOPHYTON; WORLD HEALTH; GLOBAL HEALTH;

EID: 84891603742     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.12788/j.sder.0014     Document Type: Article

References (15)

1. Ghannoum MD, Hajjeh RA, Scher R. A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43: 641-648
2. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol. 1995;133:699-703
3. Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26:397-411
4. Elewski BE. Onychomycosis: Pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11:415-429
5. Smith ES, Fleischer AB Jr, Feldman SR. Demographics of aging and skin disease. Clin Geriatr Med. 2001;17:631-641
6. Elewski B, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 1997;133:1172-1173
7. Htwe TH, Mushtaq A, Robinson SB, Rosher RB, Khardori N. Infection in the elderly. Infect Dis Clin North Am. 2007;21:711-743
8. Abdullah L, Abbas O. Common nail changes and disorders in older people: Diagnosis and management. Can Fam Physician. 2011;57:173-181
9. Tan JS, Joseph WS. Common fungal infections of the feet in patients with diabetes mellitus. Drugs Aging. 2004;21:101-112
10. Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007;21:617-638
11. Winston JA, Miller JL. Treatment of onychomycosis in diabetic patients. Clin Diabetes. 2006;24:160-166
12. Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62:411-414
13. Gupta AK, Taborda P, Taborda V, et al. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol. 2000;39:746-753
14. Rich P, Griffiths CEM, Reich K, et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol. 2008;58:224-231
15. Gupta A, Paquet M. Onychomycosis in children. J Am Acad Dermatol. 2012; 66(4 suppl 1):AB120